Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of CNTX-4975 for chronic, moderate-to-severe knee osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• CNTX-4975

Snippet

Sponsor: Centrexion Therapeutics | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED